Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6700
+0.0200 (1.21%)
NASDAQ · Last Trade: Jan 19th, 9:16 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors